Summary
The genetic generalized epilepsies (GGEs) are mainly genetically determined disorders. Although inheritance in most cases appears to be complex, involving multiple genes, variants of a number of genes are known to contribute. Pathogenic variants of SLC2A1 leading to autosomal-dominant GLUT1 deficiency account for up to 1% of cases, increasing to 10% of those with absence seizures starting before age 4 years. Copy number variants are found in around 3% of cases, acting as risk alleles. Copy number variation is much more common in those with comorbid learning disability. Common variant associations are starting to emerge from genome-wide association studies but do not yet explain a large proportion of GGEs. Although currently genetic testing is not likely to yield a diagnosis for most patients with GGEs, it can be of great importance in specific clinical situations. Providers should consider the individual patient's history in determining the utility of genetic testing.
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| THE WORRIED PARENTS
A mother presents with her infant son. She has had epilepsy since her teenage years, with absence seizures and convulsions, both of which respond to medication. She asks if her child will develop epilepsy like her. A father presents with his 6-year-old daughter.
The daughter has had difficult-to-control absence seizures since before her third birthday, as well as the occasional convulsion. He requests advice about treatment and risks to any further children. What would you say to each parent?
The genetic generalized epilepsies (GGEs), also known as idiopathic generalized epilepsies, make up around one-fourth of all epilepsies. 1 They show a combination of generalized spike and wave discharges on electroencephalography (EEG) occurring at over 2.5 Hz and otherwise normal intellect and brain imaging. 2 There are 3 common seizure types seen. Typical absence seizures show brief (5-20 s) bursts of regular spike and waves, accompanied by sudden onset and offset of lost awareness. There may be subtle facial myoclonus and drifting open of closed eyes, but postural tone is largely unaffected. Myoclonic seizures are brief jerks, usually of the axial or upper limb muscles, accompanied by a spike or poly-spike wave discharge on EEG. Generalized tonic-clonic seizures (GTCS) are the third, common seizure type in GGEs. The classical subsyndromes of GGEs are divided according to the combination of seizure types and the age of onset. In childhood absence epilepsy (CAE), typical absence seizures usually begin between 4 and 8 years of age, with multiple absences a day. For juvenile absence epilepsy (JAE), the onset is later (usually after 11 years) and absences are less frequent, and GTCS are often seen as well. Juvenile myoclonic epilepsy (JME) with onset in adolescence has prominent myoclonic seizures, often intermixed with GTCS and sometimes absence. Generalized tonic-clonic seizures can also be the sole seizure type in GGEs, often occurring first thing in the morning; GTCS alone or GTCS on awakening (GTCSA).
Although these subsyndromes are broadly accepted, the diagnostic classification for epilepsy does not draw clear lines between them, and the limits, particularly of CAE, are a matter of active debate. There are also cases that fit the broad definition of GGE but not the classical age at onset, for instance adult-onset GGE and some early onset absence epilepsies (EOAEs), where seizures start before 4 years of age. 3, 4 There are also situations where the epilepsy is consistent with GGE but intellectual impairment or autism is also present, which fall outside the strict definition of GGE but are important as the genetic causes appear to overlap. 5 
| THE GENETICS OF GGE
Genetic generalized epilepsy (or GGE), as the name suggests, is a disease for which predominant genetic contribution is suspected. Twin studies comparing monozygotic (MZ, or identical) twins with dizygotic (DZ, or fraternal) twins are useful for estimating the contribution of genetics to a disease on a population level. 6 MZ twins share all their genome, whereas DZ twins are siblings and therefore share half. Being twins, both groups have very similar environments, hopefully excluding environmental effects to compare the importance of inheritance. Concordance, the rate at which a second twin is affected given disease in the first twin, can be compared between DZ and MZ twins. Multiple sclerosis, a disease with strong environmental as well as genetic contributions, shows an MZ concordance of 30% and a DZ concordance of 4%. 7 Seizures as a whole show an MZ vs DZ concordance of 62% vs 18%, whereas GGE shows 76% vs 33%. 8 This is consistent with a largely, although not necessarily exclusively, genetic disease. Overall the rate of epilepsy in siblings of patients with GGE is around 8%. 9 This is lower than the 25% expected of a recessive or 50% expected of a dominantly inherited trait. Family histories, when present, tend to be sparse. 10 This suggests that, in most cases, multiple gene variants are needed to produce GGE. However, as of 2018, there are no accepted models on how such a presumed polygenic inheritance occurs on a genetic level, including the type of variants and the associated genes. This leaves GGE as a genetic but not necessarily inherited or familial disorder. This complexity, as well as the cultural impact of diagnosing heritable disease in many places, has prompted the ILAE to maintain idiopathic generalized epilepsy as an alternate term for the classical GGE syndromes.
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Gene variants contributing to complex disease can either be individually low impact and common, or individually high impact but rare. Both kinds of variants have been identified in GGEs, although only a minority of the gene changes needed to explain GGEs overall have been found.
| SINGLE GENES AND GGE
As with any diseases with complex inheritance, a proportion are caused by variants in single genes. Variants in the c-aminobutyric acid (GABA) receptor subunit gene GABRG2 can cause childhood absence epilepsy but do not appear to be a common cause in GGE overall 12 ; similarly, variants in GABRA1 rarely cause monogenic GGEs. 13 More important overall is SLC2A1, which codes for a glucose transporter, GLUT1. The brain is critically dependent on glucose for metabolism, and GLUT1 is the sole transporter of glucose across the blood-brain barrier. Loss of function of 1 of the 2 copies of this gene leads to GLUT1 deficiency, a condition initially described as a severe metabolic encephalopathy including intractable epilepsy, complex motor dysfunction, and intellectual disability.
14 Milder GLUT1 deficiency, initially recognized via familial cases, causes a combination of movement disorder and epilepsy with prominent absence seizures, along with intellect that is often normal. 15 The movement disorder in GLUT1 deficiency is unusual, with prolonged exercise leading to dystonia and chorea, largely confined to the limbs during exercise (paroxysmal exertional dyskinesia).
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GLUT1 deficiency is seen in 10% of those with typical absence seizures starting before 4 years of age and around
Key Points
• Genetic generalized epilepsies (GGEs) are presumed to be largely genetic disorders with complex inheritance
• GGEs are associated with different types of genetic variants-single gene disorders, copy number variants, and common variants
• GLUT1 deficiency is a potentially treatable genetic cause of GGEs, and should be considered in early onset absence epilepsy, or in patients with epilepsy and paroxysmal exercise-induced dystonia
• Genetic testing for GGEs, except for specific clinical scenarios, is currently best done in a research setting 1% of people with typical GGE overall. [17] [18] [19] With a narrow definition of EOAE that excludes not only those with intellectual impairment but also those who have ever had GTCS, myoclonic seizures, or photosensitivity on EEG, the rate of GLUT1 deficiency in EOAE is probably closer to the 1% seen in GGE overall.
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GLUT1 deficiency is also remarkable for having a specific remedy in the ketogenic diet. Ketones utilize a different transporter so that the ketogenic diet bypasses the metabolic defect, leading to excellent seizure control in even the most severe cases, and likely improvement in intellectual function, making a diagnosis of mild GLUT1 deficiency clinically important.
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| SINGLE GENE GGE MIMICS
In addition, some genetic disorders can be mistaken for GGE. This is particularly true where GGE is refractory to treatment. The epilepsy associated with most neuronal migration disorders is either focal or sufficiently severe to qualify as an epileptic encephalopathy. Subcortical band heterotopia, however, particularly with X-linked inheritance in women due to variants of the gene DCX, can occasionally present with GTCS and generalized spike and wave discharges over 2.5 Hz with normal intellect, although clearly not with normal imaging on close examination of magnetic resonance imaging (MRI). 22, 23 The progressive myoclonic epilepsies (PMEs) are a group of degenerative disorders characterized by myoclonic and convulsive seizures, action myoclonus, tremor, ataxia, and often cognitive decline, all combined with EEG showing generalized spike and waves. 24 The most common identified cause of PME is Unverricht-Lundborg disease, a recessive disease caused by variants in the gene cystatin B. 25 The presentation in Unverricht-Lundborg disease particularly, but in other PME as well, can mimic JME with GTCS starting at around 6-to 12-years of age along with myoclonus and EEG evidence of generalized spike and waves. 26 It is not until ataxia and action myoclonus appear later that the diagnosis becomes clear. In rare, mild cases of Unverricht-Lundborg disease, the clinical features can continue to mimic JME until at least middle age. 27 
| COMPLEX GENETICS: COPY NUMBER VARIANTS
Deletions and duplications of chromosomal segments, also referred to as copy number variants (CNVs), are important contributors to the genetics of neurodevelopmental disorders with complex inheritance, including GGE. 28 Recurrent deletions on chromosome 15 (15q13.3, 15q11.2) and chromosome 16 (16p13.11) are associated with GGE, with around 3% of people with GGE being carriers for 1 of these 3 deletions. 28, 29 Despite encompassing multiple genes, these CNVs are also seen in unaffected members of the general population, albeit rarely, and therefore act as risk factors rather than causative alleles. In any given family, unaffected carriers and family members with epilepsy who are not carriers for the CNV may be identified, supporting the role of the CNV as a genetic risk factor rather than a Mendelian cause of disease. 5, 30 The odds ratios suggest that approximately 1 carrier in 3 with the strongest risk allele (15q13.3) will develop GGE. Although GGE is defined by the absence of other significant brain disease, these CNVs were first described in other neurodevelopmental disorders, including autism spectrum disorders, intellectual disability, and schizophrenia. [31] [32] [33] These CNVs appear to increase risk for multiple disorders, not just in relatives but in the same individual. Those with GGE-like epilepsy and comorbid intellectual disability are significantly more likely than those with either GGE or intellectual disability alone to be carriers for such a recurrent CNV. 5, 34 Overall, although these CNVs are risk factors for epilepsy, they are also risk factors for much more disabling neurodevelopmental conditions, and when these CNVs are found, genetic counseling needs to take that into account.
| COMPLEX GENETICS: SEQUENCE VARIANTS
For discovering common variants contributing to complex disease, the established approach is the genome-wide association study (GWAS). 35 For a GWAS, large groups of cases with the disease of interest are collected along with a similarly large group of control individuals. Common single nucleotide polymorphisms (SNPs) are then genotyped across the genome and the frequency of each SNP compared between cases and controls. As there are several million common SNPs, this requires controlling for multiple comparisons.
A recent combined analysis of multiple GWAS for GGE and focal epilepsy suggests a number of common loci for GGE. 36 For epilepsy as a whole, common variant associations were shown with SNPs in the sodium channel subunit SCN1A and the cell interaction molecule, protocadherin 7 (PCDH7). Both genes are biologically plausible candidates. Pathogenic variants in SCN1A are well known to cause epilepsy, underlying most of the epileptic encephalopathy Dravet syndrome and occurring in the familial syndrome of genetic epilepsy with febrile seizures plus. 37, 38 Although PCDH7 has not been associated previously with epilepsy, another member of the gene family, PCDH19, is associated with an X-linked, female-limited epilepsy. 39 For GGE alone, common variants in the gene VRK2 showed association. This gene has not been associated previously with epilepsy outside of GWAS and is a protein kinase involved in signal transduction and apoptosis. Of interest, one of the SNPs forming the association signal in this gene has one allele that predisposes to GGE while being simultaneously protective against schizophrenia; the opposite effect of the microdeletions discussed earlier. 40 The evidence for these common variants as genetic risk factors is not yet definitive and requires replication.
Recently, a whole exome analysis of 640 cases of GGE with a family history revealed an excess of ultra-rare variants in cases compared to controls, although no individual genes reached significance with this sample size. Remarkably, there was an excess of variation in genes known to cause epileptic encephalopathies 41 including SCN1A, GABRG2, ATP1A3, and KCNQ2.
| CONCLUSION
Although the genetics of GGE is a rapidly moving and expanding field, the puzzle is far from solved. GWAS findings are statistically robust and the variants are frequently found in people with GGE; however, each of these SNP associations is of very small magnitude, with odds ratios <1.3. The effect of each GGE-associated SNP, and indeed the likely overall effect of all common variation, explains only part of the genetic contribution to GGE.
For gene changes such as SLC2A1 pathogenic variants leading to GLUT1 deficiency, each variant is of high impact but only about 1% of individuals with GGE are carriers for any of these known genetic changes. For early onset absence epilepsy, testing for GLUT1 deficiency with a lumbar puncture or sequencing has both a significant yield and treatment implications. Where GGE is combined with intellectual disability either in the individual or in a close relative, a chromosomal microarray looking for CNV is indicated. This test is, however, indicated in developmental disability more broadly, and the presence of GGE does not significantly alter that. Although massive genome sequencing projects are underway that will likely transform our understanding, at the moment genetic testing to predict recurrence of GGE in family members is indicated only in specific clinical scenarios.
| THE WORRIED PARENTS REVISITED
You sit down and listen to the first mother's concerns that she may pass on her epilepsy to her son. You explain that he has about an 8% risk of having seizures by age 20. It is far more likely that he will not have seizures and, should they occur, it is likely they will be easy to control. You further explain that there is currently no genetic test that can accurately predict if her next child will develop epilepsy. In the second case, you quickly realize that this absence epilepsy is of unusually early onset. On careful questioning, the father reveals that he had experienced prolonged cramping and jerking of the legs with playing sports at school that you realize might indicate paroxysmal exertion dyskinesia. You therefore suspect GLUT1 deficiency and discuss investigation with lumbar puncture and genetic testing. If positive, this will lead to different therapeutic options such as the ketogenic diet, and this may improve his daughter's seizure control. It will also alter your counseling advice, as further children have a 50% risk of inheriting the variant and about a 40% chance of having seizures.
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